^
BIOMARKER:

TNFRSF8 positive

i
Other names: TNFRSF8, TNF Receptor Superfamily Member 8, Tumor Necrosis Factor Receptor Superfamily Member 8, Lymphocyte Activation Antigen CD30, CD30L Receptor, Ki-1 Antigen, D1S166E, CD30, Tumor Necrosis Factor Receptor Superfamily, Member 8, Cytokine Receptor CD30, CD30 Antigen, TNFRSF8, Ki-1
Entrez ID:
Related biomarkers:
TNFRSF8 positive
HL
brentuximab vedotin
Sensitive: A1 - Approval
TNFRSF8 positive
Cutaneous T-cell Lymphoma
brentuximab vedotin
Sensitive: A1 - Approval
TNFRSF8 positive
Diffuse Large B Cell Lymphoma
brentuximab vedotin
Sensitive: A2 - Guideline
TNFRSF8 positive
NHL
CD30.CAR-T cell therapy
Sensitive: C2 – Inclusion Criteria
TNFRSF8 positive
Lymphoma
AFM13 + NK cell stimulant
Sensitive: C2 – Inclusion Criteria
TNFRSF8 positive
HL
CD30.CAR-T cell therapy
Sensitive: C3 – Early Trials
TNFRSF8 positive
Peripheral T-cell Lymphoma
BV-ICE
Sensitive: C3 – Early Trials